Detection of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: A comparison of the alkaline phosphatase and immunofluorescent techniques

European Journal of Gastroenterology and Hepatology

Volumn 9, Issue 6, 1997, Pages 575-580

  Bansi, Davinder S ^a   Bauducci, Mario ^b   Bergqvist, Annika ^c   Boberg, Kirsten ^d   Broome, Ulrika ^c   Chapman, Roger ^a   Fleming, Kenneth ^a   Jorgensen, Roberta ^e   Lindor, Keith ^e   Rosina, Floriano ^b   Schrumpf, Erik ^d  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b MOLINETTE HOSPITAL   (Italy)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e MAYO CLINIC   (United States)

Author keywords

Antineutrophil cytoplasmic antibodies; Immunoalkaline phosphatase technique; Immunofluorescence; Primary sclerosing cholangitis

Indexed keywords

ALKALINE PHOSPHATASE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; AUTOIMMUNE HEPATITIS; CHRONIC LIVER DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HEPATITIS C; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; INTERMETHOD COMPARISON; ITALY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUTROPHIL; NORWAY; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; SERODIAGNOSIS; STATISTICS; SWEDEN; UNITED STATES; VIRUS HEPATITIS;

EID: 8544276587     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199706000-00005     Document Type: Article

References (22)

1. Chapman RW, Marborgh BA, Rhodes JM, et al: Primary sclerosing cholangitis: a review of its clinical features, cholangiography and hepatic histology. Gut 1980, 21:870-877.
2. Chapman RW: Role of immune factors in the pathogenesis of primary sclerosing cholangitis. Semin Liver Dis 1991, 11:1-4.
3. Duerr RH, Targan SR, Landers CJ, et al.: Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1991, 100:1385-1391.
4. Seibold F, Weber P, Klein R, et al.: Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Gut 1992, 33:657-662.
5. Lo SK, Fleming KA, Chapman RW: Prevalence of antineutrophil antibody in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique. Gut 1992, 33:1370-1375.
6. Mulder AL, Horst C, Haagsma E, et al.: Prevalence and characterisation of neutrophil cytoplasmic antibodies in autoimmune liver diseases. Hepatology 1993, 17:411-417.
7. Pokorny CS, Norton I, McCaughan GW, et al.: Antineutrophil cytoplasmic antibody: a prognostic indicator in primary sclerosing cholangitis. J Gastroenterol Hepatol 1994, 9:40-44.
8. Lo SK, Chapman RW, Cheeseman P, et al.: Antineutrophil antibody: a test for autoimmune primary sclerosing cholangitis in childhood? Gut 1993, 34:199-202.
9. Ludwig JL, Barham SS, LaRusso NF, et al.: Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hepatology 1981, 1:632-640.
10. Wiik A: Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. Acta Pathol Microbiol Immunol Scand 1989, 97(suppl. 61):12-13.
11. Bansi DS, Fleming KA, Chapman RW: Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre and IgC subclass. Gut 1996, 38:384-389.
12. Bansi DS, Chapman RW, Fleming KA: Antineutrophil cytoplasmic antibody titre but not IgC subclass distinguishes between primary sclerosing cholangitis and autoimmune hepatitis. Gastroenterology 1995, 108:A1028.
13. Klein R, Eisenberg J, Weber P, et al.: Significance and specificity of antibodies to neutrophils detected by western blotting for the serologic diagnosis of primary sclerosing cholangitis. Hepatology 1991, 14:1147-1152.
14. Oudkerk Pool M, Roca M, Remaux D, et al.: The value of pANCA as a serological marker for ulcerative colitis in different European regions. Eur J Gastroenterol Hepatol 1994, 6:399-403.
15. Targan SR, Landers C, Vidrich A, et al.: High-titre antineutrophil cytoplasmic antibodies in type 1 autoimmune hepatitis. Gastroenterology 1995, 108:1159-1166.
16. Minuk GY, Sutherland LR, Pappas SC: Autoimmune chronic active hepatitis (lupoid hepatitis) and primary sclerosing cholangitis in two young adult females. Can J Gastroenterol 1988, 2:22-27.
17. Rabinovitz M, Demetris AJ, Bou-Abboud CF, et al.: Simultaneous occurrence of primary sclerosing cholangitis and autoimmune chronic active hepatitis in a patient with ulcerative colitis. Dig Dis Sci 1992, 37:1606-1611.
18. Lawrence SP, Sherman KE, Lawson JM, et al.: A 39 year old man with chronic hepatitis. Semin Liver Dis 1994, 14:97-105.
19. Roberts S, Poterucha JJ, Gores GJ, et al.: Overlap between type 1 autoimmune hepatitis and primary sclerosing cholangitis. Hepatology 1995, 22:129A.
20. Chapman RW: The enigma of antineutrophil antibodies in ulcerative colitis and primary sclerosing cholangitis: important genetic marker or epiphenomenon? Hepatology 1995, 21:1473-1474.
21. Shanahan F: Neutrophil autoantibodies in inflammatory bowel disease: are they important? Gastroenterology 1994, 107:586-589.
22. Bansi D, Gunson B, Neuberger J, et al.: Antineutrophil cytoplasmic antibodies after liver transplantation for primary sclerosing cholangitis. Hepatology 1995, 22:391A.